AstraZeneca PLC (LON:AZN – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are presently covering the company, Marketbeat Ratings reports. One ...

Read More »

AstraZeneca shares trade higher on UBS Upgrade

Shares of AstraZeneca (LON: AZN) traded higher on Wednesday after UBS revised its recommendation for the pharmaceutical giant’s stock to "neutral" from "sell." ...

Read More »

Outperform-rated AstraZeneca stock gains traction with oncology and Symbicort growth

On Monday, Leerink Partners updated their financial outlook on AstraZeneca (LON:AZN) (NASDAQ: NASDAQ:AZN), increasing the price target to $87.00 from $86.00 while maintaining an Outperform rating. The ...

Read More »

Here's Why AstraZeneca (LON:AZN) Has Caught The Eye Of Investors

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...

Read More »

Here's Why AstraZeneca (LON:AZN) Has Caught The Eye Of Investors

Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like AstraZeneca (LON:AZN). While this ...

Read More »